Pre-clinical characterization of GMP grade CCL21-gene modified dendritic cells for application in a phase I trial in Non-Small Cell Lung Cancer
<p>Abstract</p> <p>Background</p> <p>Our previous studies have demonstrated that transduction of human dendritic cells (DC) with adenovirus encoding secondary lymphoid chemokine, CCL21, led to secretion of biologically active CCL21 without altering DC phenotype or viabi...
Main Authors: | Sharma Sherven, Batra Raj K, Zeng Gang, Kurimoto Pam S, Luo Jie, Peebles Katherine, Hazra Saswati, Takedatsu Hiroko, Baratelli Felicita, Dubinett Steven M, Lee Jay M |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2008-07-01
|
Series: | Journal of Translational Medicine |
Online Access: | http://www.translational-medicine.com/content/6/1/38 |
Similar Items
-
Overexpression of CCL-21/Secondary Lymphoid Tissue Chemokine in Human Dendritic Cells Augments Chemotactic Activities for Lymphocytes and Antigen Presenting Cells
by: Strieter Robert, et al.
Published: (2003-11-01) -
Novel CCL21-vault nanocapsule intratumoral delivery inhibits lung cancer growth.
by: Upendra K Kar, et al.
Published: (2011-05-01) -
CCL21 Cancer Immunotherapy
by: Yuan Lin, et al.
Published: (2014-05-01) -
Interaction of polysialic acid with CCL21 regulates the migratory capacity of human dendritic cells.
by: Marieke Bax, et al.
Published: (2009-09-01) -
Dendritic Cell Migration Toward CCL21 Gradient Requires Functional Cx43
by: Richard Ruez, et al.
Published: (2018-03-01)